Be Clinic Ready! Corealis Pharma provides services on a contract basis in the areas of Formulation & Process Development as well as in small scale Clinical Trial Material (Phase I and II) Manufacturing and the packaging of solid dosage forms (tablets & capsules) to pharmaceutical and biotech companies. Our services include: API characterization; salt selection; pre-formulation; formulation & process development; analytical method development; stability storage & testing; technical transfer and scale-up; cGMP manufacturing & packaging of Phase I and II CTM; dossier support for American, European, and Canadian submissions. Our experts have access to modern well equipped R&D and cGMP manufacturing & packaging facilities that allow them to successfully complete the most challenging and complex mandates. The primary objective of Corealis and its staff is to make every one of their customers succeed. Corealis Pharma Inc. offers personalized and efficient services in the areas of Formulation Development and Clinical Supply Manufacturing of solid oral dosage forms.
Looking for a particular Corealis Pharma Inc. employee's phone or email?
The Corealis Pharma Inc. annual revenue was $13.5 million in 2026.
Patrick Frankham is the Vice President of Business Development of Corealis Pharma Inc..
34 people are employed at Corealis Pharma Inc..
Corealis Pharma Inc. is based in Laval, Quebec.
The NAICS codes for Corealis Pharma Inc. are [325, 32, 3254, 32541].
The SIC codes for Corealis Pharma Inc. are [28, 283].